Dr. Yarchoan's research efforts have also focused on AIDS malignancies, and he led the first clinical studies showing that paclitaxel was an effective therapy for Kaposi's sarcoma and that thalidomide had activity in this disease.
Dr. Yarchoan's research efforts have also focused on AIDS malignancies, focusing on the pathogenesis and treatment of Kaposi's sarcoma and other virus-associated tumors. He led the first clinical studies showing that paclitaxel was an effective therapy for Kaposi's sarcoma and that thalidomide had activity in this disease.